Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation
Go back to Elanco Announces Collaboration Agreement with Novozymes for Nutritional Health Innovation| eLandia International, Inc. (NYSE: ELAN) | Delayed: 23.58 -0.39 (1.63%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $23.97 | 52 Week High | $0.65 | |||
| Open | $23.91 | 52 Week Low | $0.03 | |||
| Day High | $23.96 | P/E | N/A | |||
| Day Low | $23.53 | EPS | $-0.60 | |||
| Volume | 2,837,050 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1124.40 +0.49 (0.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1123.91 | 52 Week High | $88.16 | |||
| Open | $1127.61 | 52 Week Low | $67.88 | |||
| Day High | $1138.79 | P/E | 260.28 | |||
| Day Low | $1119.00 | EPS | $4.32 | |||
| Volume | 1,276,593 | |||||
